Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37708912

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2023 Oct
First author
Aronson SL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2023 Oct;24(10):1057-1059. doi: 10.1016/S1470-2045(23)00447-3.
    note
    Source null
    related pmid
    37797627
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2023 Dec;24(12):e457. doi: 10.1016/S1470-2045(23)00471-0.
    note
    Source null
    related pmid
    38039999
    relationship
    Comment in

Authors and identifiers

  1. name
    Aronson SL
    type
    Author
  2. name
    Lopez-Yurda M
    type
    Author
  3. name
    Koole SN
    type
    Author
  4. name
    Schagen van Leeuwen JH
    type
    Author
  5. name
    Schreuder HWR
    type
    Author
  6. name
    Hermans RHM
    type
    Author
  7. name
    de Hingh IHJT
    type
    Author
  8. name
    van Gent MDJM
    type
    Author
  9. name
    Arts HJG
    type
    Author
  10. name
    van Ham MAPC
    type
    Author
  11. name
    van Dam PA
    type
    Author
  12. name
    Vuylsteke P
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Aronson SL
    type
    Author
  2. name
    Lopez-Yurda M
    type
    Author
  3. name
    Koole SN
    type
    Author
  4. name
    Schagen van Leeuwen JH
    type
    Author
  5. name
    Schreuder HWR
    type
    Author
  6. name
    Hermans RHM
    type
    Author
  7. name
    de Hingh IHJT
    type
    Author
  8. name
    van Gent MDJM
    type
    Author
  9. name
    Arts HJG
    type
    Author
  10. name
    van Ham MAPC
    type
    Author
  11. name
    van Dam PA
    type
    Author
  12. name
    Vuylsteke P
    type
    Author
bibliography ids
  1. nci-bib-3c0de6f3747aebcb87f0f16d
book metadata
content sha256
c2eae4f44128f4309e9336c26d9146430d7ffd1e14cfecef02617b3a903608c8
document type
citation
dois
  1. 10.1016/S1470-2045(23)00396-0
electronic publication date
display
2023 Sep 11
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:37708912
immutable id
pubmed:37708912@c2eae4f44128f4309e9336c26d9146430d7ffd1e14cfecef02617b3a903608c8
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
10
name
The Lancet. Oncology
nlm unique id
100957246
pages
1109-1118
volume
24
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2023 Oct;24(10):1057-1059. doi: 10.1016/S1470-2045(23)00447-3.
    note
    Source null
    related pmid
    37797627
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2023 Dec;24(12):e457. doi: 10.1016/S1470-2045(23)00471-0.
    note
    Source null
    related pmid
    38039999
    relationship
    Comment in
outcomes validated
false
pmid
37708912
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
9169c63fdb54f7f40d4e6319b5d6fc2dc49f4e045e51e9637ae2733b058fe147
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 Oct
precision
month
year
2023
publication types
  1. Randomized Controlled Trial
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37708912/
title
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial.

Preserved source evidence · Not medical advice